Virtus Lifesci Biotech Clinical Trials ETF (BBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBC | VHT | IBB | ||
| Company | Virtus Lifesci Biotech Clinical Trials ETF | Healthcare ETF Vanguard | Nasdaq Biotechnology Ishares ETF | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NASDAQ | ||
| Open | 42.38 | 289.82 | 173.14 | ||
| High | 42.51 | 295.64 | 175.67 | ||
| Low | 42.09 | 289.81 | 172.16 | ||
| Latest | 42.47 | 295.51 | 175.37 | ||
| Change | -0.24 | +4.09 | +1.49 | ||
| % Change | -0.57% | +1.40% | +0.86% | ||
| Volume | 5,200 | 154,300 | 1,386,600 | ||
| 20-Day Average Volume | 21,955 | 234,925 | 1,967,425 | ||
| Previous Close | 42.71 | 291.42 | 173.88 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 41.21 | 289.92 | 173.80 | ||
| 20-Day Raw Stochastic | 77.81% | 98.80% | 66.32% | ||
| 20-Day Relative Strength | 57.36 | 58.36 | 54.36 | ||
| Weighted Alpha | +127.22 | +13.75 | +34.00 | ||
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 64% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.03% since 02/20/26 | +1.94% since 02/20/26 | +0.56% since 02/20/26 | ||
| Low | 40.72 on 02/23/26 | 288.55 on 02/26/26 | 170.90 on 02/26/26 | ||
| High | 43.50 on 02/25/26 | 295.64 on 02/27/26 | 178.29 on 02/25/26 | ||
| 1-Month | |||||
| %Chg | -0.78% since 01/27/26 | +2.07% since 01/27/26 | -0.86% since 01/27/26 | ||
| Low | 38.83 on 02/05/26 | 284.77 on 01/30/26 | 169.62 on 02/11/26 | ||
| High | 43.50 on 02/25/26 | 295.64 on 02/27/26 | 178.29 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | +13.20% since 11/26/25 | -0.09% since 11/26/25 | +0.98% since 11/26/25 | ||
| Low | 35.14 on 12/02/25 | 281.00 on 12/09/25 | 165.09 on 01/05/26 | ||
| High | 44.10 on 01/22/26 | 298.61 on 01/07/26 | 179.64 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +85.24% since 08/27/25 | +16.15% since 08/27/25 | +26.54% since 08/27/25 | ||
| Low | 22.43 on 08/29/25 | 249.57 on 09/25/25 | 137.63 on 08/29/25 | ||
| High | 44.10 on 01/22/26 | 298.61 on 01/07/26 | 179.64 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 38,220 | 17,780,837 | 8,680,814 | ||
| Shares Outstanding, K | 900 | 60,170 | 49,500 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 1.01 | 0.67 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.655 on 12/22/25 | 1.665 on 12/17/25 | 0.183 on 12/16/25 | ||
| Next Ex-Dividends Date | 12/22/25 | 12/17/25 | 12/16/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.40 | 26.01 | ||